These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26756896)

  • 1. Performance assessment of the Thai National Center for Pharmacovigilance.
    Kaewpanukrungsi W; Anantachoti P
    Int J Risk Saf Med; 2015; 27(4):225-37. PubMed ID: 26756896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacovigilance activities in ASEAN countries.
    Suwankesawong W; Dhippayom T; Tan-Koi WC; Kongkaew C
    Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1061-9. PubMed ID: 27174034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal detection for Thai traditional medicine: examination of national pharmacovigilance data using reporting odds ratio and reported population attributable risk.
    Wechwithan S; Suwankesawong W; Sornsrivichai V; McNeil EB; Jiraphongsa C; Chongsuvivatwong V
    Regul Toxicol Pharmacol; 2014 Oct; 70(1):407-12. PubMed ID: 24945744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Summarizing of medicinal alerts in Ivory Coast from 2001 till 2010].
    N'Guessan-Irié AG; Yavo JC; Guillaume Amari AS; Yapi AD
    Therapie; 2012; 67(3):251-6. PubMed ID: 22874492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Erice Manifesto: for global reform of the safety of medicines in patient care.
    Drug Saf; 2007; 30(3):187-90. PubMed ID: 17343426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggregate analysis of regulatory authority assessors' comments to improve the quality of periodic safety update reports.
    Jullian S; Jaskiewicz L; Pfannkuche HJ; Parker J; Lalande-Luesink I; Lewis DJ; Close P
    Pharmacoepidemiol Drug Saf; 2015 Sep; 24(9):971-9. PubMed ID: 26175055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. vigiGrade: a tool to identify well-documented individual case reports and highlight systematic data quality issues.
    Bergvall T; Norén GN; Lindquist M
    Drug Saf; 2014 Jan; 37(1):65-77. PubMed ID: 24343765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reorganisation of European pharmacovigilance. Part 2. From spontaneous reports to agency reviews and decisions.
    Prescrire Int; 2015 Feb; 24(157):50-4. PubMed ID: 25802924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacovigilance in Europe: Place of the Pharmacovigilance Risk Assessment Committee (PRAC) in organisation and decisional processes.
    Laroche ML; Batz A; Géniaux H; Féchant C; Merle L; Maison P
    Therapie; 2016 Apr; 71(2):161-9. PubMed ID: 27080834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of herbal products in Thailand: an analysis of reports in the thai health product vigilance center database from 2000 to 2008.
    Saokaew S; Suwankesawong W; Permsuwan U; Chaiyakunapruk N
    Drug Saf; 2011 Apr; 34(4):339-50. PubMed ID: 21417506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacovigilance in oncology: evaluation of current practice and future perspectives.
    Baldo P; De Paoli P
    J Eval Clin Pract; 2014 Oct; 20(5):559-69. PubMed ID: 24909067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Good pharmacovigilance practices: technology enabled.
    Nelson RC; Palsulich B; Gogolak V
    Drug Saf; 2002; 25(6):407-14. PubMed ID: 12071777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of a new pharmacovigilance tool: Simplified online reporting for general practitioners].
    Humbert X; Chrétien B; Sassier M; Coquerel A; Alexandre J; Fedrizzi S
    Sante Publique; 2018; 30(2):225-232. PubMed ID: 30148310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The new pharmacovigilance legislation in practice].
    Broekmans AW; Mol PG
    Ned Tijdschr Geneeskd; 2014; 158():A7129. PubMed ID: 24846112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Safety Evaluation in China.
    Li L; Yin J
    Curr Allergy Asthma Rep; 2019 Jul; 19(9):39. PubMed ID: 31321555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Assessment of the National Pharmacovigilance Systems in East Africa: Ethiopia, Kenya, Rwanda and Tanzania.
    Barry A; Olsson S; Minzi O; Bienvenu E; Makonnen E; Kamuhabwa A; Oluka M; Guantai A; Bergman U; van Puijenbroek E; Gurumurthy P; Aklillu E
    Drug Saf; 2020 Apr; 43(4):339-350. PubMed ID: 31919794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacovigilance: methods, recent developments and future perspectives.
    Härmark L; van Grootheest AC
    Eur J Clin Pharmacol; 2008 Aug; 64(8):743-52. PubMed ID: 18523760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving paradigms in pharmacovigilance.
    Brewster W; Gibbs T; Lacroix K; Murray A; Tydeman M; Almenoff J
    Curr Drug Saf; 2006 May; 1(2):127-34. PubMed ID: 18690923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The French pharmacovigilance system: structure and missions].
    Welsch M; Alt M; Richard MH; Imbs JL
    Presse Med; 2000 Jan; 29(2):102-6. PubMed ID: 10682040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.